Stroke is the third leading cause of death behind diseases of the heart and cancer and the most important reason for medical disability.
Approximately five in every 1,000 people overall and three in every 100 people aged 65 years
and above suffer a stroke in industrialised countries.
A stroke occurs when a blood clot blocks a vessel or artery, or when a blood vessel breaks, interrupting blood flow
to an area of the brain. When a stroke occurs, it kills brain cells in the immediate area. This can happen anywhere
from a few minutes after the stroke start to a few hours later.
Indicated as thrombolytic treatment in acute ischaemic stroke.
Indicated to reduce the risk of stroke in patients who have had transient ischaemia of the
brain or completed ischaemic stroke due to thrombosis.
Disclaimer: We recognise that the Internet serves a
global community. The pharmaceutical industry, however, is subject to country specific
regulatory considerations, which affect the information we can provide on our products. In
addition the registration status of pharmaceutical products may not be the same in
different regions of the world and the approved product labels may also differ according
to country specific requirements.
Therefore please check the registration details of this/these product(s) locally in order
to get up-to-date information.
